ORIX Corporation (IX) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $1.82 et chiffre d'affaires de $17.70B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $1,492.75 vs est $1.82 (dépassé +81984.7%). 2025: réel $1,538.70 vs est $2.14 (dépassé +71750.7%). Précision des analystes: 0%.
Estimations du BPA — IX
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1,492.75
vs Est $1.82
▲ 99.9% off
2025
Actual $1,538.70
vs Est $2.14
▲ 99.9% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving.
Estimations du CA — IX
1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $2,814.361B
vs Est $17.699B
▲ 99.4% off
2025
Actual $2,874.821B
vs Est $18.855B
▲ 99.3% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Les autres consultent aussi
